Log In

Tom Chang Edit Profile

also known as Tom Chang MD

ophthalmologist

Tom Chang MD is a world-renowned clinician, surgeon, educator, and ophthalmologist living in Pasadena, CA. The Co-CEO of Acuity Eye Group, he is listed in Who's Who and Best Doctors in America.

Background

Tom Chang MD is a doctor and educator. He stays on the leading edge of medicine and provides each patient under his care with the best possible treatment. Chang does stem cell research and performed the first stem cell transfer to treat dry macular degeneration. He spent five years working as an assistant professor of ophthalmology at the University of British Columbia.

He later went on to hold the same position at the Doheny Eye Institute for six years. As an educator, Tom Chang MD has spoken at more than 120 lectures in 15 countries around the world. In addition to his other positions, Dr. Chang is a scientific advisor for several Fortune 500 companies. His reputation earned him several high-profile patients, which include professional athletes and the CEOs of well-known companies.

Education

The Toronto Medical School is where Dr. Chang earned his doctor of medicine, and he went on to complete his residency training at the University of Western Ontario. Dr. Chang finished three fellowships related to retinal diseases. At John Hopkins University, he earned a fellowship in macular disease.

He also spent time studying at the Emory Eye Center, which is where he completed his vitreoretinal surgery fellowship. Dr. Chang was always passionate about his studies and put in the effort to be the best in his field. He is proud of his educational achievements and is thrilled to use his knowledge and experience to help others.

Career

Tom Chang currently works at the Acuity Eye Group, a clinic that works only with the top ophthalmologists in the nation. He specializes in retina diseases and surgery and helps his patients protect and maintain their vision.

He helps diagnose macular degeneration, diabetic retinopathy and a variety of other conditions that impact eyesight. He works closely with his patients to help them understand the conditions they are facing and what options make the most sense for their goals.

When a patient approaches Tom Chang MD with eyesight problems, his first steps are to learn about the patient, discover when the problem started and perform an eye exam. During each exam, Dr. Chang takes photographs of different parts of the eye, including the retina, optical disk and blood veins.

After completing the exam and learning about the patient, Dr. Chang reveals treatment options and tells his patients what they can likely expect in the future. The No. 1 goal is to catch eye diseases before they have the opportunity to cause lasting damage and permanent vision loss. Tom Chang MD offers second opinions to those seeking additional information about their eye conditions.

Achievements

  • Dr. Chang has achieved many awards during his career, highlighting his dedication to providing the best possible medical services to those under his care. His achievements also showcase his education and how much knowledge he has in the field.

    Dr. Chang is the associate editor of Ophthalmology, and he is the editor-in-chief of the Retina Times. Evidence-Based Eye Care was happy to place Dr. Chang on the editorial board. Who’s Who and Best Doctors of America have mentioned the achievements of Dr. Chang.

    • Supervised the weekly Retinal Rounds (attended by all residents, fellows, and attendings)

    • Vancouver Hospital representative for Postgraduate Residency Training Committee

    • Participant in the Resident’s day research committeeJudge: Resident’s day research competition. UBC Dept. of Ophthalmology

    • Director of Continuing Medical Education at the University of British Columbia

    • Participant in the annual “Update for General Practitioners” course

Works

  • article

    • YAG retinal photocoagulation in rabbit eyes

      (Canadian Journal of Ophthalmology)

      1992
    • Low dose Tamoxifen Retinopathy: A case report of retinopathy resolution

      (Canadian Journal of Ophthalmology)

    • Trans-scleral YAG retinal photocoagulation: A new therapeutic modality

      (Canadian Journal of Ophthalmology)

      1992
    • Congenital trichomegaly, pigmentary degeneration of the retina and growth retardation (Oliver-McFarlane syndrome):28-year follow-up of the first reported case

      (Canadian Journal of Ophthalmology)

      1993
All works

References